Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Kamgar M, Hobbs GA, Davidson R, Dorbin D, Herrera J, Langenheim JF, Burge RA, Aldakkak M, Conrardy RD, Szabo A, Thalji SZ, Mayer B, Grahl JJ, Chung BY, Phan A, Thomas JP, Seo YD, Evans DB, Christians KK, Erickson B, Hall WA, George B, Tsai S, Lytle NK, Der CJ, Kurzrock R, McFall T.

Open source

DOI: 10.1158/0008-5472.can-25-0018
Published: 2026-04-01
Container: Cancer Res
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-25-0018,
  title = {Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.},
  author = {Kamgar M and  Hobbs GA and  Davidson R and  Dorbin D and  Herrera J and  Langenheim JF and  Burge RA and  Aldakkak M and  Conrardy RD and  Szabo A and  Thalji SZ and  Mayer B and  Grahl JJ and  Chung BY and  Phan A and  Thomas JP and  Seo YD and  Evans DB and  Christians KK and  Erickson B and  Hall WA and  George B and  Tsai S and  Lytle NK and  Der CJ and  Kurzrock R and  McFall T.},
  year = {2026},
  journal = {Cancer Res},
  doi = {10.1158/0008-5472.can-25-0018},
  url = {https://doi.org/10.1158/0008-5472.can-25-0018}
}

RIS

TY  - JOUR
TI  - Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.
AU  - Kamgar M
AU  -  Hobbs GA
AU  -  Davidson R
AU  -  Dorbin D
AU  -  Herrera J
AU  -  Langenheim JF
AU  -  Burge RA
AU  -  Aldakkak M
AU  -  Conrardy RD
AU  -  Szabo A
AU  -  Thalji SZ
AU  -  Mayer B
AU  -  Grahl JJ
AU  -  Chung BY
AU  -  Phan A
AU  -  Thomas JP
AU  -  Seo YD
AU  -  Evans DB
AU  -  Christians KK
AU  -  Erickson B
AU  -  Hall WA
AU  -  George B
AU  -  Tsai S
AU  -  Lytle NK
AU  -  Der CJ
AU  -  Kurzrock R
AU  -  McFall T.
PY  - 2026
JO  - Cancer Res
DO  - 10.1158/0008-5472.can-25-0018
UR  - https://doi.org/10.1158/0008-5472.can-25-0018
ER  -

APA

M, K., GA, H., R, D., D, D., J, H., JF, L., RA, B., M, A., RD, C., A, S., SZ, T., B, M., JJ, G., BY, C., A, P., JP, T., YD, S., DB, E., KK, C., B, E., WA, H., B, G., S, T., NK, L., CJ, D., R, K., & T., M. (2026). Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.. Cancer Res. https://doi.org/10.1158/0008-5472.can-25-0018

Source records

europe-pmc · retrieved 2026-09-26T01:34:40.538Z